{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:20:18Z","timestamp":1789053618593,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCMF-MP-114-02-01"],"award-info":[{"award-number":["TCMF-MP-114-02-01"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04981-6","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:09:56Z","timestamp":1767424196000},"page":"2481-2489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic efficacy of multimodal therapy for patients with interstitial cystitis\/bladder pain syndrome refractory to previous bladder monotherapy"],"prefix":"10.1007","volume":"58","author":[{"given":"Wan-Ru","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fong","family":"Jhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"7","key":"4981_CR1","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/nau.70107","volume":"44","author":"B Hayes","year":"2025","unstructured":"Hayes B, Namugosa M, Evans RJ et al (2025) Patient related outcomes for\u00a0interstitial\u00a0cystitis\/bladder pain syndrome recommendations for clinical trials and general urology practice. Neurourol Urodyn 44(7):1455\u20131465","journal-title":"Neurourol Urodyn"},{"key":"4981_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.70106","author":"K Buford","year":"2025","unstructured":"Buford K, Peters KM, Riedl C et al (2025) Global consensus on interstitial cystitis\/bladder pain syndrome: an update on therapeutic treatments. Neurourol Urodyn. https:\/\/doi.org\/10.1002\/nau.70106","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"4981_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/tcmj.tcmj_166_24","volume":"37","author":"WR Yu","year":"2024","unstructured":"Yu WR, Jiang YH, Jhang JF, Kuo HC (2024) Repeated intravesical injections of platelet-rich plasma are safe and effective in the treatment of interstitial cystitis\/bladder pain syndrome. Tzu Chi Med J 37(1):72\u201379","journal-title":"Tzu Chi Med J"},{"issue":"1","key":"4981_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/nau.25027","volume":"42","author":"LS Jhang","year":"2023","unstructured":"Jhang LS, Hsieh WC, Huang TX et al (2023) Use of low-intensity extracorporeal shock wave therapy in the management of interstitial\u00a0cystitis\/bladder pain syndrome patients: a thirty case study in a tertiary medical center. Neurourol Urodyn 42(1):65\u201372","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"4981_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5213\/inj.2040104.052","volume":"24","author":"CC Lin","year":"2020","unstructured":"Lin CC, Huang YC, Lee WC, Chuang YC (2020) New frontiers or the treatment of interstitial cystitis\/bladder pain syndrome-focused on stem cells, platelet-rich plasma, and low-energy shock wave. Int Neurourol J 24(3):211\u2013221","journal-title":"Int Neurourol J"},{"issue":"1","key":"4981_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/nau.25089","volume":"42","author":"S Sutherland","year":"2023","unstructured":"Sutherland S, Grace Kelly A, Ryden A, Dmochowski RR, Reynolds WS, McKernan LC (2023) Compensatory coping and depression in women with interstitial cystitis\/bladder pain syndrome. Neurourol Urodyn 42(1):322\u2013329","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"4981_CR7","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.juro.2014.10.086","volume":"193","author":"JN Krieger","year":"2015","unstructured":"Krieger JN, Stephens AJ, Landis JR et al (2015) Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP study. J Urol 193(4):1254\u20131262","journal-title":"J Urol"},{"issue":"1","key":"4981_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00345-024-05366-7","volume":"43","author":"WR Yu","year":"2024","unstructured":"Yu WR, Jhang JF, Jiang YH, Kuo HC (2024) Pelvic floor muscle pain is associated with higher symptom scores and bladder pain perception in women with interstitial cystitis and bladder pain syndrome. World J Urol 43(1):9","journal-title":"World J Urol"},{"issue":"6","key":"4981_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/iju.14229","volume":"27","author":"Y Akiyama","year":"2020","unstructured":"Akiyama Y, Luo Y, Hanno PM, Maeda D, Homma Y (2020) Interstitial cystitis\/bladder pain syndrome: the evolving landscape, animal models and future perspectives. Int J Urol 27(6):491\u2013503","journal-title":"Int J Urol"},{"key":"4981_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-025-01044-4","author":"JF Jhang","year":"2025","unstructured":"Jhang JF, Yu WR, Jiang YH, Kuo HC (2025) Pathophysiology and potential multimodal therapeutic strategies for IC\/BPS. Nat Rev Urol. https:\/\/doi.org\/10.1038\/s41585-025-01044-4","journal-title":"Nat Rev Urol"},{"issue":"1","key":"4981_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/tcmj.tcmj_172_23","volume":"36","author":"WR Yu","year":"2023","unstructured":"Yu WR, Jiang YH, Jhang JF, Kuo HC (2023) Cystoscopic characteristic findings of interstitial cystitis and clinical implications. Tzu Chi Med J 36(1):30\u201337","journal-title":"Tzu Chi Med J"},{"issue":"3","key":"4981_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/JU.0000000000001031","volume":"204","author":"HH Lai","year":"2020","unstructured":"Lai HH, Pickersgill NA, Vetter JM (2020) Hunner lesion phenotype in interstitial cystitis\/bladder pain syndrome: a systematic review and meta-analysis. J Urol 204(3):518\u2013523","journal-title":"J Urol"},{"key":"4981_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/JU.0000000000002756","volume":"208","author":"JQ Clemens","year":"2022","unstructured":"Clemens JQ, Erickson DR, Varela NP, Lai HH (2022) Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J Urol 208:34\u201342","journal-title":"J Urol"},{"key":"4981_CR14","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/iju.14234","volume":"27","author":"Y Homma","year":"2020","unstructured":"Homma Y, Akiyama Y, Tomoe H et al (2020) Clinical guidelines for interstitial cystitis\/bladder pain syndrome. Int J Urol 27:578\u2013589","journal-title":"Int J Urol"},{"issue":"1","key":"4981_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12894-020-00597-3","volume":"20","author":"T Jiang","year":"2020","unstructured":"Jiang T, Zhou X, Chen Z et al (2020) Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II\/III interstitial cystitis\/bladder pain syndrome. BMC Urol 20(1):36","journal-title":"BMC Urol"},{"key":"4981_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/path.6040","volume":"259","author":"JF Jhang","year":"2023","unstructured":"Jhang JF, Liu CD, Hsu YH et al (2023) EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis\/bladder pain syndrome with Hunner\u2019s lesion. J Pathol 259:276\u2013290","journal-title":"J Pathol"},{"issue":"3","key":"4981_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/biomedicines12030522","volume":"12","author":"HC Kuo","year":"2024","unstructured":"Kuo HC, Peng CW, Jiang YH, Jhang JF (2024) Urinary viral spectrum in patients with interstitial cystitis\/bladder pain syndrome and the clinical efficacy of valacyclovir treatment. Biomedicines 12(3):522","journal-title":"Biomedicines"},{"issue":"11","key":"4981_CR18","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s00192-019-03970-5","volume":"30","author":"J Pape","year":"2019","unstructured":"Pape J, Falconi G, De Mattos Lourenco TR, Doumouchtsis SK, Betschart C (2019) Variations in bladder pain syndrome\/interstitial cystitis (IC) definitions, pathogenesis, diagnostics and treatment: a systematic review and evaluation of national and international guidelines. Int Urogynecol J 30(11):1795\u20131805","journal-title":"Int Urogynecol J"},{"key":"4981_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/tcmj.tcmj_313_21","volume":"35","author":"YH Jiang","year":"2022","unstructured":"Jiang YH, Jhang JF, Kuo HC (2022) The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis. Tzu Chi Med J 35:31\u201337","journal-title":"Tzu Chi Med J"},{"issue":"5","key":"4981_CR20","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno PM, Erickson D, Moldwin R, Faraday MM, American Urological Association (2015) Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J Urol 193(5):1545\u20131553","journal-title":"J Urol"},{"key":"4981_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","volume":"104","author":"HC Kuo","year":"2009","unstructured":"Kuo HC, Chancellor MB (2009) Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome. BJU Int 104:657\u2013661","journal-title":"BJU Int"},{"key":"4981_CR22","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3390\/diagnostics11122238","volume":"11","author":"Y Akiyama","year":"2021","unstructured":"Akiyama Y (2021) Biomarkers in interstitial cystitis\/bladder pain syndrome with and without Hunner lesion: a review and future perspectives. Diagnostics 11:2238","journal-title":"Diagnostics"},{"issue":"Suppl 2","key":"4981_CR23","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.5213\/inj.1632712.356","volume":"20","author":"JF Jhang","year":"2016","unstructured":"Jhang JF, Kuo HC (2016) Pathomechanism of interstitial cystitis\/bladder pain syndrome and mapping the heterogeneity of disease. Int Neurourol J 20(Suppl 2):S95\u2013S104","journal-title":"Int Neurourol J"},{"key":"4981_CR24","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/nau.24019","volume":"38","author":"WR Yu","year":"2019","unstructured":"Yu WR, Peng TC, Yeh HL, Kuo HC (2019) Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis\/bladder pain syndrome. Neurourol Urodyn 38:1602\u20131610","journal-title":"Neurourol Urodyn"},{"key":"4981_CR25","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.3390\/jcm11206221","volume":"11","author":"WR Yu","year":"2022","unstructured":"Yu WR, Jhang JF, Chen BY, Ou SR, Li HM, Kuo HC (2022) Multimodal treatment with cognitive behavioral therapeutic intervention plus bladder treatment is more effective than monotherapy for patients with interstitial cystitis\/bladder pain syndrome\u2014a randomized clinical trial. J Clin Med 11:6221","journal-title":"J Clin Med"},{"key":"4981_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/JU.0000000000003847","volume":"211","author":"JM Lackner","year":"2024","unstructured":"Lackner JM, Clemens JQ, Radziwon C et al (2024) Cognitive behavioral therapy for chronic pelvic pain: what is it and does it work? J Urol 211:539\u2013550","journal-title":"J Urol"},{"key":"4981_CR27","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/nau.24726","volume":"40","author":"J Natarajan","year":"2021","unstructured":"Natarajan J, Ahmed T, Patil S et al (2021) Pain and functionality improved when underlying neuromuscular dysfunction addressed in chronic pelvic pain patients. Neurourol Urodyn 40:1609\u20131615","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"4981_CR28","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s00192-022-05115-7","volume":"33","author":"MA Spruijt","year":"2022","unstructured":"Spruijt MA, Klerkx WM, Kelder JC, Kluivers KB, Kerkhof MH (2022) The efficacy of botulinum toxin A injections in pelvic floor muscles in chronic pelvic pain patients: a systematic review and meta-analysis. Int Urogynecol J 33(11):2951\u20132961","journal-title":"Int Urogynecol J"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04981-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:18:30Z","timestamp":1782483510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04981-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["4981"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04981-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8045403\/v1","asserted-by":"object"}]},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"IRB: IRB code: 113-023-A, the study was approved by the Research Ethics Committee of Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation on December\/05\/2024.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}